Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lucentis in Polypoidal Choroidal Vasculopathy
NCT00837330Phase 2Completed
- Sponsor
- Southeast Retina Center
- Start
- May 2006
- Primary completion
- Dec 2010
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ranibizumab in polypoidal choroidal vasculopathy (PCV), sponsored by Southeast Retina Center. Started May 2006; status: completed.
02
Drugs
ranibizumab
03
Conditions
polypoidal choroidal vasculopathy (PCV)
Beyond the preview
Go deeper on NCT00837330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00837330.